Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Apotea Sverige AB
AB
Active
Org 5566516489
Sveavägen 168, 113 46
Stockholm
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2003 · 22 years old
812 employees
Monitor
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Apotea Sverige AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
8.0B
6.0B
4.0B
2.0B
0B
2020: 4.1B
4.1B
2020
2021: 4.6B (+11% vs 2020)
4.6B
+11%
2021
2022: 4.9B (+6% vs 2021)
4.9B
+6%
2022
2023: 5.3B (+10% vs 2022)
5.3B
+10%
2023
2024: 6.4B (+20% vs 2023)
6.4B
+20%
2024
EBITDA
SEK millions
462M
347M
231M
116M
0M
2020: 230M
230M
2020
2021: 162M (-30% vs 2020)
162M
-30%
2021
2022: 95M (-41% vs 2021)
95M
-41%
2022
2023: 190M (+100% vs 2022)
190M
+100%
2023
2024: 371M (+95% vs 2023)
371M
+95%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
6 407 750
5 335 876
4 872 800
4 579 485
4 125 857
Staff expenses
—
—
—
—
—
EBITDA
371 239
190 338
94 772
162 023
229 628
Depreciation & amort.
−73 688
−64 951
−37 761
−26 470
−13 504
EBIT
297 551
125 387
57 011
135 553
216 124
Net financials
3 768
−85
278
64
−146
Profit before tax
273 237
139 523
57 289
135 616
215 979
Tax
−58 241
−30 417
−13 031
−26 753
−46 173
Net profit
214 996
109 106
44 258
108 863
169 806
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
1 369 184
1 071 581
973 944
877 730
731 989
Equity
556 214
370 871
336 886
319 086
243 171
Long-term debt
0
0
0
0
0
Short-term debt
812 971
689 744
611 871
533 458
463 632
Total debt
812 971
689 744
611 871
533 458
463 632
Financial ratios
5-year trend
EBITDA margin
5,8 %
This company
15,8 %
Market median
This company
Market median
63% below market
2020
2024
Equity ratio
40,6 %
This company
38,2 %
Market median
This company
Market median
6% above market
2020
2024
Return on equity
38,7 %
This company
18,4 %
Market median
This company
Market median
110% above market
2020
2024
Net profit margin
3,4 %
This company
8,1 %
Market median
This company
Market median
58% below market
2020
2024
Asset turnover
4,68×
This company
1,12×
Market median
This company
Market median
318% above market
2020
2024
Debt / equity
1,46×
This company
0,62×
Market median
This company
Market median
135% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Apotea Sverige AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
